Cancer genetics has come a long way in the last two decades, leading to increased prevention and improved treatment options. Today, research is shining the light on why certain people have an increased risk for cancer.
“It took us 20 years to get where we are today with the knowledge of BRCA1/2, but we are starting to find changes in other genes that are explaining a history of cancer in families,” says Huma Q. Rana, MD, clinical director for Dana-Farber’s Center for Cancer Genetics and Prevention. “These new genes we’re identifying are likely to make a difference in prevention and treatment in the future.”
Rana recently discussed the truth around BRCA testing and genetic risk in a live video webchat hosted by the Susan F. Smith Center for Women’s Cancers at Dana-Farber. The chat, which featured questions submitted by patients and live viewers, covered topics on hereditary breast and ovarian cancer risk, genetic testing costs and procedures, as well as new findings around gene mutations that may increase cancer risk.
View the video of the July 16 webchat below. For more information on cancer genetics, visit the website for Dana-Farber’s Center for Cancer Genetics and Prevention.